New Delhi, Jan 11 (UNI) The Food Safety and Standards Authority of India (FSSAI) has provided clarity on the regulatory framework surrounding the use of methylcobalamin, a form of Vitamin B12, in health supplements, medical purpose and nutraceutical products.
The Union Health Ministry’s decision to lift the ban on methylcobalamin, a critical vitamin B12 derivative, is yet to be formalized, leaving its regulatory status in limbo despite scientific backing and growing demand for its use in treating conditions such as diabetic neuropathy.